.Nature Medicine, Posted online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Viewpoint asks for introduction of people with MASLD as well as size of liver end results in cardio-- renal-- metabolic tests, when information recommend mechanistically possible advantages as well as scientific safety-- and describes points to consider for trial layout as well as regulatory approval.